Programming - Hypertension Scientific Sessions

Save the date!
October 7-11, 2026
Hyatt Regency Crystal City | Arlington, Virginia

Hypertension26 Poster Presentations (PDF)

Hypertension 2026 Schedule-at-a-Glance

Wednesday, Oct. 7 Activities
Time	Activity
5:00 p.m. to 6:30 p.m.	American Heart Association Welcome Exchange: Innovations in Hypertension Care Location: Washington A&B (Free to attend, ticketed event)
7:00 p.m. to 9:00 p.m.	Member Welcome Reception for Council on Hypertension and KCVD Members Location: Chesapeake View (Free to attend, ticketed event)

Thursday, Oct. 8 Activities
Time	Activity
7:00 a.m. to 8:00 a.m.	Light Breakfast Location: Regency Ballroom Foyer
7:30 a.m. to 9:00 a.m.	Session 1 Welcome Remarks and Keynotes Location: Regency Ballroom C-F & Center 7:30 a.m. American Heart Association President-Elect Remarks Svati H. Shah, MD, MS, MHS, FAHA 7:45 a.m. Welcome Remarks Jane F. Reckelhoff, PhD, FAHA \| Chair, Council on Hypertension Steven D. Crowley, MD \| Chair, Hypertension 2026 Scientific Sessions Program Committee 8:00 a.m. Metabolic Reprogramming via HIF-1α to Confront Kidney and Cardiovascular Disease Volker Haase, MD 8:30 a.m. HIF-2α inhibition and Pheochromocytoma/Paraganglioma Camilo Jimenez Vasquez, MD
9:00 a.m. to 10:00 a.m.	Session 2 Aldosterone: Biology and Recent Clinical Trials Location: Regency Ballroom C-F & Center Moderators: Celso Gomez Sanchez & Ulrike Muscha Steckelings, MD, PhD, FAHA, ISHF 9:00 a.m. Recent Clinical Trials Jamie Dwyer, MD 9:30 a.m. Mechanisms for disrupting aldosterone signals to afford protection in hypertension and CVD David Ellison, MD
10:00 a.m. to 10:30 a.m.	Networking Event Meet the Keynote Speakers Location: Potomac Rooms Moderators: Benard Ogola, PhD and Monica Santisteban, PhD (limited attendance) Coffee and snacks will be served Early-career attendees will have the opportunity to engage with experienced professionals, gain valuable insights into their career paths and achievements, and receive guidance to help shape their own professional development journey. Volker Haase, MD Vanderbilt University Medical Center Camilo Jimenez Vasquez, MD University of Texas MD Anderson Cancer Center David H. Ellison, MD Oregon Health and Science University Jamie Dwyer, MD University of South Carolina
10:00 to 10:30 a.m.	Learning Studio – From Evidence to Practice: How Clinically Validated Cuffless 24-Hour Ambulatory BP Monitoring is Changing Hypertension Diagnosis and Management Location: Regency Ballroom A&B Speakers: Gianfranco Parati, MD – Professor of Cardiovascular Medicine, University of Milano-Bicocca & Istituto Auxologico Italiano Ziad Zoghby, MD, MBA, FACP – Associate Professor of Medicine at Mayo Clinic Maria Carolina Delgado-Lelievre, MD – Founder & Director, Comprehensive Hypertension Center at University of Miami Elias G. Hellou, MD – Invasive Cardiologist & Research Collaborator, Mayo Clinic This session brings together a distinguished panel of leading clinical researchers and hypertension specialists for a compelling discussion on optimizing hypertension management using actionable 24-hour BP data. The panel will explore the clinical validation and real-world utility of cuffless ABPM, share evidence-based strategies for treatment optimization, and provide an exclusive first look at new clinical data from a multinational cohort of 600 hypertensive patients. Sponsored by Biobeat
10:00 a.m. to 10:30 a.m.	Coffee Break Location: Regency Ballroom Foyer
10:30 a.m. to 11:00 a.m.	Session 3 The Donald Seldin Lecture Location: Regency Ballroom C-F & Center SGLT2 Inhibition in Salt-Sensitive Hypertension: From Kidney Metabolism to Cardiovascular Protection Alexander Staruschenko, PhD, FAHA
11:00 a.m. to 12:00 p.m.	Session 4 Concurrent Oral Abstract Sessions 04A Inflammation Nation Location: Regency Ballroom C-F & Center Moderators: Jing (Jason) Wu, PhD, FAHA and Annet Kirabo, DVM, MSc, PhD, FAHA 11:00 Intestinal Immune Cell Trafficking and Salt Nicola Wilck, MD 01 11:30 GLP-1/GIP Receptor Agonism Lowers Blood Pressure and Decreases Disease Activity in an Experimental Model of Systemic Lupus Erythem Erin Taylor 02 11:45 Central Galantamine Administration Lowers Blood Pressure and Reduces Brainstem and Renal Inflammation in Systemic Lupus Erythematosus Keisa Mathis 04B Decoding Resistant Hypertension Location: Presidents Quarters Moderators: Daniel T. Lackland, DrPH, FAHA and J. Brian Byrd, MD, MS 11:00 Invited Speaker: Tackling Resistant Hypertension: Evidence-Based Strategies Naomi DL Fisher, MD 03 11:30 Persistent Apparent Treatment-Resistant Hypertension and Cardiovascular Risk in the Jackson Heart Study Lama Ghazi 04 11:45 Characteristics Associated with Endogenous Hypercortisolism in Individuals with Resistant Hypertension and Cardiovascular Disorders: Analyses from the MOMENTUM Study Omar Al Dhaybi 04C Clinical Trials and Care Delivery Innovation In Hypertension Location: Potomac Room Moderators: Keith C. Ferdinand, MD, FAHA and Cian McCarthy, MB, BCh, BAO, SM 05 11:00 Effectiveness of Implementation Strategies for Remote Blood Pressure Monitoring in Safety Net Primary Care Clinics: Main Results from the REACH-SNS RCT Courtney Lyles 06 11:15 Effect of DASH Groceries on Blood Pressure by Hypertension Severity or Treatment Status: Results from the GoFresh and GoFreshRx Trials Samantha Chin 07 11:30 AM Antihypertensive Medication Intensification in Pharmacist-Led versus Primary Care-Based Management in a Safety-Net Health System Valy Fontil 08 11:45 Efficacy and Safety of the Selective Aldosterone Synthase Inhibitor Lorundrostat in Moderate-to-Severe Obstructive Sleep Apnea and Hypertension: Explore-OSA Randomized Crossover Trial Reena Mehra
12:05 p.m. to 12:35 p.m.	Learning Studio A Novel Aldosterone-Targeted Treatment for Patients with Uncontrolled Hypertension Location: Regency Ballroom A&B Speaker: George Thomas, MD Sponsored by AstraZeneca Pharmaceutical
1:00 p.m. to 1:30 p.m.	Learning Studio - Integrating Renal Denervation Into Contemporary Hypertension Care Location: Regency Ballroom A&B Speakers: Iliana S. Hurtado Rendón MD, FACC Maria Carolina Delgado-Lelievre, MD Dr. Florian Rader, MD, MSc Sponsored by ReCor Medical
1:30 p.m. to 2:00 p.m.	Session 5 Harriet Dustan Award Lecture Location: Regency Ballroom C-F & Center Sex, Gender and Cardiovascular Diseases; The Next Frontier Louise Pilote MD, MPH, PhD, FRCPC
2:00 p.m. to 3:00 p.m.	Session 6 Macula Densa Location: Regency Ballroom C-F & Center Moderators: Mariela Mendez, BS, PhD and Thiago Bruder, PhD, FAHA 2:00 Imaging macula densa function in blood pressure regulation Janos Peti-Peterdi, MD, PhD 2:30 The macula densa’s role in mechanisms of AKI and resulting CKD Ruisheng Liu, MD, PhD
3:00 p.m. to 3:30 p.m.	Coffee Break Location: Regency Ballroom Foyer
3:30 p.m. to 5:30 p.m.	Session 7 Concurrent Oral Abstract Sessions 07A Trainee Advocacy Highlighted Oral Abstract Session: Beyond Blood Pressure: Emerging Biology and Clinical Impact of the RAAS Location: Regency Ballroom C-F & Center Moderators: Candee Barris, PhD and Laena Pernomian, PhD 09 3:30 The Case for Screening: Aldosterone-Renin Testing is Associated with Lower Mortality and Cardiovascular Events in Resistant Hypertension Tayyaba Saleem 10 3:45 Intercalated Cell Cyclooxygenase-2 Restrains Aldosterone-Induced Hypertension, Volume Expansion, and Potassium Loss Amir Aalami 11 4:00 Female Mice Are Resistant to Angiotensin II-Induced Trained Immunity and Atheroprogression Emma Hope 12 4:15 CD4+ T Cell-Targeted Nanoparticle Silencing of ROCK2 Attenuates Angiotensin II-Induced Hypertensive Cardiorenal Injury Independent of Blood Pressure Daniel Fehrenbach 13 4:30 Time of Day Contributes to the CXCR2 Dependence of Angiotensin II-Induced Hypertension Lance Benson 14 4:45 PM Microglial ACE2 as a Central Link Between Hypertension and Type 2 Diabetes Uma Priya Mohan 15 5:00 Chronic RAAS Suppression Drives Hypoxic Vascular Remodeling and Reveals Urinary Biomarkers of Silent Kidney Injury Lucas Almeida 16 5:15 The Hidden Cardiotoxic Toll of Aldosterone Excess: A National Inpatient Comparison of Primary Aldosteronism vs. Essential Hypertension Nava Sharma 07B Trainee Advocacy Highlighted Oral Abstract Session: Sex Specific Mechanisms of Hypertension Location: President's Quarters Moderators: Nathan Campbell, PhD and Sara Zarate, PhD 17 3:30 The Sex Paradox in Hypertension: Higher Prevalence and Cardiovascular Mortality but Lower Treatment Receipt in Men Kwabena Odei-Kumi 18 3:45 Endothelin-1 Signaling in Dendritic Cells Promotes Hypertension and Arterial Stiffness in a Sex-Dependent Manner Abigail Brooks 19 4:00 Renin in the Nucleus Ambiguus Differentially Regulates Autonomic Function in Male and Female Mice Kathren Kaminski 20 4:15 Renal Aromatase Activity Evokes Female-Specific Natriuresis and Blood Pressure Regulation Frank Kiyimba 21 4:30 Protective Role of STAT3 Inhibition in Androgen-Induced Hypertension in Polyendocrine Metabolic Ovarian Syndrome Samar Rezq 22 4:45 Menopausal Status-Specific Associations Among Akkermansia muciniphila, Gut Dysbiosis, and Blood Pressure Tania Akter Jhuma 23 5:00 High Leptin Pregnancy Causes Male Specific Hypertension, Blood Pressure Variability and Circadian Disruption in Offspring of Preeclampsia Mouse Model Mona Elgazzaz 24 5:15 Sex Differences in the Association Between SVEP1 and Blood Pressure: Evidence from the SALTY Trial, All of Us, and UK Biobank Mahmoud Hamieh Concurrent C (Clinical Track Sessions) AI, Wearables, and Oversight in Hypertension Care Location: Potomac Rooms 3:30 – 4:30 7C1: Beyond the Cuff: Wearables and Next-Generation BP Monitoring Technologies Moderators: Gianfranco Parati, MD and Eugene Yang, MD, FACC 3:30 Unlocking Physiologic Signals: What Waveforms Reveal Beyond Blood Pressure Rama Mukkamala, PhD 3:45 Smartwatches and Wearables: Consumer Tools for Hypertension Detection Dean Picone, PhD 4:00 Navigating the FDA: Validation and Approval for Novel BP Measurement Devices Kimberly Crowley 4:15 Panel discussion with Q and A Panelists: Hae-Young Lee, MD; Jordana B. Cohen, MD, MSCE; Christine Chen, MD; Ziad Zoghby, MD, MBA, FACP 4:30 – 5:30 7C2: Smarter Hypertension: Harnessing AI for Detection and Management Moderators: Matthew Alexander, MD, PhD, FAHA and Tammy Brady, MD, PhD 4:30 Mining the EHR: Can We Identify Sub-phenotypes of Primary Hypertension? Jaclyn Hall, PhD 4:45 Predicting Pediatric Hypertension: AI for Early Detection and Treatment Derek Ng, PhD, ScM 5:00 Implementing AI to Improve Blood Pressure Management Tina Ann Thompson, MD 5:15 Panel discussion with Q and A Panelists: Paul Drawz, MD, MHS, MS and Gabriel Tajeu, DrPH, MPH
5:30 p.m. to 7:00 p.m.	Poster Session 1 and Reception Includes the TAC Poster Competition Hypertension26 Poster Presentations (PDF) Sponsored by Hypertension, an American Heart Association Journal
7:00 p.m. to 8:00 p.m.	Networking Event: Mid-Career Mentorship Networking Roundtables Location: Tidewater II Managing People and Finances Curt Sigmund, PhD, FAHA, and Thu Le, MD, FAHA Building Collaborations Babbette LaMarca, PhD, and Jennifer Pollock, PhD Alternative Funding Sources Uta Erdbrüegger, MD and Paul Welling, MD Remaining Scientifically Relevant Mingyu Liang, MB, PhD, and Alicia McDonough, PhD, FAHA

Friday, Oct. 9 Activities
Time	Activity
7:00 a.m. to 8:00 a.m	Coffee Location: Regency Ballroom Foyer
7:15 a.m. to 7:45 a.m.	Learning Studio: Renal Denervation Today: What Hypertension Specialists Should Know About Emerging Evidence Location: Regency Ballroom A&B Speakers: Naomi D.L. Fisher, MD, Brigham and Women's Hospital Director of Hypertension Services at the Brigham and Women’s Hospital Associate Professor of Medicine at Harvard Medical School Taisei Kobayashi, MD, LCDR, USNR, Penn Heart and Vascular Center Director, Cath Lab, Corporal Michael J. Crescenz Veterans Affairs Medical Center Associate Professor of Clinical Medicine (Cardiovascular Medicine) Sponsored by Boston Scientific
8:00 a.m. to 9:00 a.m.	Session 8 Location:Regency Ballroom C-F & Center Cognition and Dementia in Hypertension Moderators: Sean D Stocker, PhD and Eric Lazartigues, PhD, FAHA 8:00 Basic and immune mechanisms of cognitive impairment in hypertension Daniela Carnevale, PhD 8:30 Cerebral small vessel disease and dementia in human hypertension Rebecca Gottesman, MD, PhD
9:00 a.m. to 10:30 a.m.	Poster Session 2 and Breakfast Reception Location: Independence Ballroom Hypertension26 Poster Presentations (PDF)
10:30 a.m. to 12:00 p.m.	Session 9 Concurrent Oral Abstract Sessions 09A Highlights in Pregnancy Hypertension Location: Regency Ballroom C-F & Center Moderators: Babbette LaMarca, PhD, FAHA and Jessica Faulkner, PhD, FAHA 10:30 AM From Placental Ischemia to Maternal Hypertension: Immune Mechanisms and Therapeutic Opportunities in Preeclampsia Denise C Cornelius, PhD, FAHA 25 11:00 AM Prenatal Fentanyl Exposure, Cardiometabolic Dysfunction and Opioid Use Vulnerability: A GLP-1-Based Therapeutic Strategy Analia Loria 26 11:15 AM APOL1 Risk Variants: A Causal Driver and Therapeutic Target in Preeclampsia Vivikta Rao 27 11:30 AM Modulating CD4+ T Cell Pathogenicity via Diet Alleviates Renal Dysfunction and Hypertension in Pregnancy Gregory Hall 28 11:45 AM Expression of Circulating Second-Trimester microRNAs is Associated with Preeclampsia Among White but Not Black Participants Mitali Ray 09B Aging and Hypertension Location: Presidents Quarters Moderators: Zoe Arvanitakis, MD, MS, EMBA and Lorenzo Carnevale, PhD 10:30 AM Evidence-based Approaches for Blood Pressure Control Across the Lifespan Katherine Mills, PhD, FAHA 29 11:00 AM Brain and Muscle ARNT-Like-Protein-1 and Ovarian Hormones Interact to Regulate Body Fluid Homeostasis in Sprague Dawley Rats Maria Venegas 30 11:15 AM Hypertensive Outcomes in Women with Polycystic Ovary Syndrome and Hypertension Nael Rehman 31 11:30 AM Beat-to-Beat Blood Pressure Variability and Incident Hypertension in Normotensive Older Adults Sunan Gao 32 11:45 AM Activation of COX-1/EP2 Axis Contributes to Aging-Associated Renal Injury via Intrarenal RAS Peng Xie 09C Off the Cuff: Blood Pressure Measuring and Monitoring Location: Potomac Rooms Moderators: Kelsey B. Bryant, MD, MPH, MS and Mohammed A. Rafey MD, FASH, FASN 33 10:30 AM Comparing the Effect of Two Scalable Remote Hypertension Monitoring Programs on Home Blood Pressure in Primary Care Patients with Uncontrolled Hypertension Rushelle Byfield 34 10:45 AM Beyond Orthostatic Hypotension: Longitudinal Orthostatic Blood Pressure Patterns, Measurement Timing, and Risk of Incident Dementia in Community-Based Older Adults Ye Zhang 35 11:00 AM Integrating 24-Hour Ambulatory Blood Pressure Level and Variability for Earlier and Better Risk Stratification: The Multi-Ethnic Study of Atherosclerosis Wenxin Zhang 36 11:15 AM Patient-Owned Home Blood Pressure Devices Commonly Disagree with Automated Clinic Reference Measurements Arnav Mehra 37 11:30 AM Real-World Factors Influencing Concordance Between Home and Ambulatory Blood Pressure Monitoring Ritu Trivedi 38 11:45 AM Masked Hypertension and Higher Fall Risk in Older Adults: The Atherosclerosis Risk in Communities Study Frances Wang
12:00 p.m. to 1:00 p.m.	TAC CHAMP Lunch Event Location: Chesapeake View (By Invitation only)
12:15 p.m. to 12:45 p.m.	Learning Studio: Beyond Medication: Advancing Hypertension Care with the Symplicity™ Blood Pressure Procedure Location: Regency Ballroom A&B Speakers: Dharmesh Patel, MD, FACC, Stern Cardiovascular Jeremy Bock, MD, FACC, Virginia Heart Supreeti Behuria, MD, FACC, Northwell Health Sponsored by Medtronic
1:00 p.m. to 1:30 p.m.	Learning Studio: The Next Era in the Treatment of Hypertension Location: Regency Ballroom A&B Speakers: Marc Cohen, MD, FACC Chairman, Department of Medicine Formerly, Director, Division of Cardiology Newark Beth Israel Medical Center Professor of Medicine, Rutgers Health - New Jersey Medical School Sponsored by Idorsia Pharmaceuticals
1:30 p.m. to 3:00 p.m.	Session 10 Concurrent Oral Abstract Sessions 10A Brain Function in Hypertension Location: Regency Ballroom C-F & Center Moderators: Pablo Nakagawa, PhD, FAHA and Yumei Feng Earley, MD, PhD 1:30 PM Endothelial Piezo1 Hyperactivity Drives Neurovascular Dysfunction in Hypertension Osama Harraz, PhD 39 2:00 PM Optogenetic Stimulation of Glutamatergic Neurons in the Hypothalamic Paraventricular Nucleus Produces Frequency-Dependent Changes in Renal Function and Blood Pressure Sean Stocker 40 2:15 PM Deletion of Angiotensin II Type I Receptors in Cholinergic Neurons Increases Vagal Tone in Male Mice Mina Ghobrial 41 2:30 PM Asprosin: A Hypertensive Adipokine Meghan Turner 42 2:45 PM Hypertension Impairs Cerebrospinal Fluid Dynamics: The Role of Antihypertensive Treatment in a Longitudinal Study Sebastiano La Ferla 10B Reimagining the Vascular Paradigm Location: Presidents Quarters Moderators: Camilla Ferreira Wenceslau, PhD, FAHA and Pablo A. Ortiz, PhD 43 1:30 PM Elevated Blood Pressure Promotes Perivascular Adipose Tissue Remodeling with Enhanced Fibrosis and Reduced Adipogenesis Requires Piezo1 Signaling C. Javier Rendon 44 1:45 PM Endothelial Nrf2 Deficiency Induces Coronary Endothelial Dysfunction and Impairs Coronary Microvascular Perfusion Neha Dhyani 45 2:00 PM Early Life Stress Drives Aortic Wall Remodeling and Transcriptional Reprogramming of Aortic Vasa Vasorum Endothelial Cells Gillian Kelly 46 2:15 PM A Novel NGAL-GAL3 Axis Emerges in Mineralocorticoid Receptor-Driven Aortic Valve Remodeling in Chronic Kidney Disease Frederic Jaisser 47 2:30 PM Vascular Smooth Muscle Cell Xist Protects Against Hypertension-Induced Arterial Stiffening Through Regulation of ROCK1 Signaling and Calcium Handling Benard Ogola 48 2:45 PM Notch3 Regulation of Brown Adipose Tissue Anti-Contractile Effects Augusto Montezano Concurrent C (Clinical Track Session) Resistant Hypertension: Role of Hyperaldosteronism and Hypercortisolism Location: Potomac Rooms Moderators: Jenifer Brown, MD, and William Cushman, MD, MACP, FAHA 1:30 PM Identifying patients who warrant screening for hormonally-driven hypertension in different clinical settings Adina Turcu, MD, MS 1:52 PM How should we currently be thinking about subclinical primary aldosteronism and cortisol excess? Greg Hundemer, MD, MPH 2:14 PM The current state of confirmatory testing and detecting lateralization in primary aldosteronism Alexander Leung, MPH, MD, FRCPC 2:46 PM Genetic manifestations of hyperaldosteronism and hypercortisolism Ashima Gulati, MD, PhD
3:00 p.m. to 3:30 p.m.	Coffee Break Regency Ballroom Foyer
3:30 to 4:45 p.m.	Session 11 Annual Hypertension Awards Session Location: Regency Ballroom C-F & Center Stephanie Watts Award Finalist Presentations 3:30 PM PBMCs From Patients With Lupus Predispose Humanized Mice to Salt-Sensitive Hypertension and Lupus-Associated Immune Activation Mohammad Saleem, PhD 3:40 PM Chronic Kidney Disease Drives Microglial Immuno-Metabolic Reprogramming and Excess Sympathetic Nerve Activity Swati Sharma, PhD 3:50 PM Established Investigator Award for Clinical Hypertension Lecture Sex Hormones and Cardiovascular-Kidney Health: From Physiology to Clinical Impact Annet Kirabo, DVM, MSc, PhD, FAHA 4:15 PM Harry Goldblatt Award for New Investigators Hypertension, Neurovascular Dysfunction, and Cognitive Decline Monica M. Santisteban, PhD
5:00 p.m. to 5:30 p.m.	Session 12 Lewis K. Dahl Memorial Lecture Location: Regency Ballroom C-F & Center Inflammasomes, B Cells and T Cells: Immune Drivers of Hypertension and Kidney Disease Grant Drummond, PhD, FAHA
6:00 p.m. to 7:15 p.m.	Learning Studio Location: Regency Ballroom A&B Shared Challenges, Different Angles: A CKM Debate A Friendly, Evidence-Based Debate on Hypertension and Kidney Health The Cardiovascular-Kidney-Metabolic (CKM) Health Initiative
7:00 p.m. to 10:00 p.m.	Trainee Advocacy Mixer Event Location: Chesapeake View

Saturday, Oct. 10 Activities
Time	Activity
7:00 a.m. to 7:30 a.m.	Light Breakfast Location: Regency Ballroom Foyer
7:30 a.m. to 8:30 a.m.	Session 13 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (read CKMS Guideline) Location: Regency Ballroom C-F & Center 7:30 AM Overview of New Cardiovascular-Kidney-Metabolic Syndrome Guideline Chiadi Ndumele, MD, PhD, MS, FAHA 7:45 AM Kidney in Cardiovascular-Kidney-Metabolic Syndrome Janani Rangaswami, MD, FAHA 8:00 AM Risk assessment in Cardiovascular-Kidney-Metabolic Syndrome Sadiya S. Khan, MD, MSc, FAHA 8:15 AM Holistic Interdisciplinary Approach to Cardiovascular-Kidney-Metabolic Syndrome Tiffany M. Powell, MD, MPH, FAHA
8:30 a.m. to 9:00 a.m.	Session 14 Council on Kidney in Cardiovascular Disease Early Career Session Location: Regency Ballrom C-F & Center Moderators: Jennifer C. Sullivan, PhD, FAHA and Uta Erdbrügger, MD 49 8:30 AM Early Proximal Tubular Mitochondrial Adaptation Distinguishes Salt-Sensitive from Salt-Resistant Rats Sri Rahavi Boovarahan 50 8:40 AM Post-Adrenalectomy Reductions in Kidney Function in Primary Aldosteronism Appear to Be Related to the Severity of Primary Aldosteronism Hannah Wickham 51 8:50 AM Association of Pre-Transplant Hypertensive End Stage Kidney Disease with Post-Kidney Transplant Blood Pressure Pawaruj Rirermsoonthorn
8:00 a.m. to 9:00 a.m.	Session 14C (concurrent) (Clinical Track Session) Measurement and Remote Monitoring: What Clinicians Need to Know Location: Potomac Rooms Moderators: Timothy Plante, MD, MHS and Rama Mukkamala, PhD 8:00 AM Device development: from the oscillometric envelope to FDA clearance Bruce Friedman, MD 8:20 AM Device prioritization for out-of-office measurement Carissa Baker Smith, MD, MPH, MS, FAHA 8:40 AM Importance of the cuff for measurement accuracy: challenges with obesity, pediatric populations, and home devices Speaker: Tammy Brady, MD, PHD
9:00 a.m. to 10:00 a.m.	Session 15 Concurrent Oral Abstract Sessions 15A Aldosterone Signals: Where's Aldo? Location: Regency Ballroom C-F & Centre Moderators: Lily Xu, MD, MPH and Robert S Hoover, MD, FAHA 9:00 AM Rethinking (Primary) Aldosteronism Giacomo Rossitto, MD 52 9:30 AM A Novel Humanized Knock-In Rat Model Allows Functional Expression of the Human Aldosterone Synthase Frederic Jaisser 53 9:45 AM Endothelin-1/ETB Receptor Signaling is Required for Leptin-Mediated Aldosterone Production and Endothelial Dysfunction in Female Mice Yoichi Ono 15B Gut Check Location: Presidents Quarters Moderators: Justine Abais-Battad, PhD and Jennifer Pluznick, PhD 9:00 AM Intestinal Vagal Serotonin Signaling Links Gut Dysbiosis to Hypertension Jasenka Zubcevic, PhD 54 9:30 AM Sex Chromosome Complement Drives Gut Microbiota Composition in Dahl Salt-Sensitive Rats Samuel Walton 55 9:45 AM Antibiotic-Guided Microbiome Screening Identifies Protective Ligilactobacillus murinus in Experimental Hypertension Hendrik Bartolomaeus Concurrent C (Clinical Track Sessions) Making Hypertension Care Work in Real-world Clinics Location: Potomac Rooms Moderators: Jeremy Van-T Hof, MD and Katherine Foti, PhD, MPH 9:00 AM Standardized hypertension management algorithms: measurement, diagnosis, and prescription of SPC Marc Jaffe, MD 9:10 AM Out-of-office BP integration and remote monitoring implementation Sharon Rikin, MD, MS 9:20 AM Coverage changes, reimbursement landscape, and billing for home and remote BP Kate Kirley, MD, MS 9:30 AM Strategy pathways Hilary Wall, MPH 9:40 AM Panel Discussion
10:00 a.m. to 10:30 a.m.	Coffee Break Location: Regency Foyer
10:30 a.m. to 12:00 p.m.	Session 16 Concurrent Oral Abstract Sessions 16A Trainee Advocacy Highlighted Oral abstract session TAC Oral Award Abstract Session Location: Regency Foyer C-F Moderators: Monica M. Santisteban, PhD and Benard Ogola PhD 56 10:30 AM Myocardial Infarction-Induced Heart Failure Induces Loop Diuretic Resistance and Distal Convoluted Tubule Hyperplasia in Mice Isaac Baiden 57 10:45 AM Live-Cell Biosensor Assays Reveals a Complex Interplay of Biased Signaling Profiles in Angiotensin AT1 Receptor Mutants Shah MD Minhajul Abedin 58 11:00 AM RelA in Antigen Presenting Cells Constrains the Hypertensive Response Taylor Kress 59 11:15 AM DASH-Patterned Groceries Lower 24-Hour Blood Pressure Among Black Adults with High Blood Pressure in the GoFresh and GoFreshRx Trials Joanna Papaioannou 60 11:30 AM Associations Between Formulary Restriction and Time to Blood Pressure Control in the Los Angeles Barbershop Blood Pressure Study Neil Zhang 61 11:45 AM Prevalence of Medication Adherence to Spironolactone and its Relationship to Plasma Renin Activity in Resistant Hypertension or Primary Aldosteronism John Giacona 16B Trainee Advocacy Highlighted Oral abstract session TAC Oral Abstract Session- Inflammation Without Borders: Multisystem Drivers of Hypertension Location: Presidents Rooms Moderators: Kanokwan Bunsawat, PhD and Daniel J Fehrenbach, PhD 62 10:30 AM Ancestry-Linked DARC Deficiency Shifts the Inflammatory Mechanisms of HIV-Associated Endothelial Dysfunction Without Further Elevating Blood Pressure Beryl Khakina 63 10:45 AM T cell Specific Deficiency of Lymphocyte Adaptor Protein LNK Promotes Kidney Damage and End Organ Inflammation Ariane Imulinde Sugi 64 11:00 AM Role of Hypertension on Vascular Health, Estrogen Receptor Expression, and Neuroinflammation Chase Richard 65 11:15 AM Neuroimmune Crosstalk Drives Microglia-Dependent Neuronal Dysfunction in Hypertension Drew Theobald 66 11:30 AM Chronic Stress Exposure Elevates Blood Pressure and Correlates with Decreased Hypothalamic and Renal Mitochondrial Respiration in a Mouse Model of Pristane-Induced Lupus Noelle Frambes 67 11:45 AM Impact of Adverse Childhood Experiences on Immunophenotypes in Adolescence Gillian Kelly Concurrent C Hypertension CPC Session Location: Potomac Rooms A young woman with hypokalemia and hypertension Jehan Zahid Bahrainwala, MD and Vivek Bhalla, MD, Stanford University Renal denervation for intractable hypertension due to hyperactivation of the sympathetic nervous system Jacob Stein, MD, NY Presbyterian Brooklyn Methodist Hospital and Debbie L Cohen, MD, University of Pennsylvania
12:00 p.m. to 1:00 p.m.	Networking Event: Meet the Hypertension Editors
12:15 p.m. to 12:45 p.m.	Learning Studio Cracking The Code: Uncover A Hidden Driver of Resistant Hypertension Location: Regency Ballroom A&B Speakers: Hanford Yau, MD, CCD, FACP, FACE Associate Director of Fellowship Training Endocrinology, Diabetes & Metabolism University of Central Florida College of Medicine/HCA Florida GME Consortium Orlando, FL Raymond Townsend, MD, FAHA, FASH Professor of Medicine Department of Internal Medicine-Renal University of Pennsylvania Philadelphia, PA Sponsored by Corcept Therapeutics
1:00 p.m. to 1:30 p.m.	Learning Studio Rethinking Hypertension in Older Adults: Blood Pressure, Brain, and Biology Location: Regency Ballroom A&B Speaker: Jorge Plutzky, MD Sponsored by Mineralys Therapeutics
1:30 p.m. to 3:00 p.m.	Session 17 Concurrent Oral Abstract Sessions 17A CKM Syndrome: Selected Advances in Basic and Clinical Science Location: Regency Ballroom C-F & Center Moderators: Thu H. Le, MD, FAHA and TBD 68 1:30 PM Dynamin-Related Protein 1 in Leptin Receptor Neurons Regulates Metabolic Homeostasis and Cardiovascular Function Deng-Fu Guo 69 1:45 PM Serum Uric Acid as a Biomarker of Cardiovascular-Kidney-Metabolic Syndrome Staging: A 2011-2018 NHANES Analysis Thanin Asawaroekwisoot 70 2:00 PM Triglyceride Glucose Index as a Predictor of Reduced Kidney Function in Hypertensive Adults Micah Okwah 71 2:15 PM Epidemiological Trends in Obesity-Associated Hypertension Mortality Among Young Adults in the United States: An Age Period Cohort Analysis Asad Ullah Wasim 72 2:30 PM Endothelin as a Therapeutic Target Across the Cardiovascular-Kidney-Metabolic (CKM) Continuum: A Post-Hoc Analysis of the PRECISION Study John Flack 72.5 2:45 PM New Insights Into Renal Mechanisms of GLP-1RAs: Semaglutide Directly Dilates Afferent Arterioles via Vascular Smooth Muscle Cell GLP-1 Receptors Janice Tang 17B Renin Angiotensin System: Pep(tide) Talks Location: Presidents Quarters Moderators: Alicia A. McDonough, PhD, FAHA and Tianxin Yang, MD, PhD, FAHA 1:30 PM From Angiotensin II to Antigen Presentation: Endothelial Mechanosensing in Hypertension Justin P. Van Beusecum, PhD 73 2:00 PM Spatial BOLD-MRI Reveals Silent Renal Hypoxia Before GFR Decline in ACE Inhibitor-Induced Arteriolar Hypertrophy Jason Smith 74 2:15 PM Angiotensin-(1-5) is a Novel Hormone of the RAS with AT2 Receptor-Mediated Antihypertensive Properties Ulrike Steckelings 75 2:30 PM RAAS Biomarker Profiles and Treatment Response to Renal Artery Stenting in Atherosclerotic Renal Artery Stenosis: A Post Hoc Analysis of CORAL Devon Gaur 76 2:45 PM ACE2 Amplification Offers a Distinctive and Favorable Profile on RAS Peptides and Plasma Renin as Compared to ACE Inhibition Umair Rehman Concurrent C (Clinical Track Session) Early Life Origins and Lifecourse Tracking of Blood Pressure Location: Potmac Rooms Moderators: Mingyu Zhang, PhD, and Anastasia S. Mihailidou, BSc, PhD 1:30 PM Birth history and its role in development of hypertension Joseph Flynn, MD, MS 1:45 PM Youth hypertension and long-term CV and cognitive outcomes Rahul Chanchlani, MD 2:00 PM Arterial characteristics across age continuum Josh Samuels, MD, MPH 2:15 PM Sex differences in physiology and trajectory of blood pressure across the lifespan Natalie Ann Bello, MD, MPH 2:30 PM Physiologic and pathologic changes in blood pressure during pregnancy Janet Catov, PhD, MS 2:45 PM Panel Discussion and Q&A
3:00 p.m. to 3:30 p.m.	Break
3:30 p.m. to 4:30 p.m.	Session 18 3:30 PM Council on Hypertension Mid-Career Award for Research Excellence Lecture Location: Regency Ballroom C-F & Center The Vasculature in Hypertension and Cardiometabolic Disease: From Mechanisms to New Perspectives Eric Belin de Chantemèle, DSc, FAHA 4:00 PM KCVD Mid-Career Achievement Award Lecture Sex Hormones and Cardiovascular-Kidney Health: From Physiology to Clinical Impact Sofia Ahmed, MD, MMSc
4:30 p.m. to 5:30 p.m.	Session 19 Concurrent Oral Abstract Sessions 19A Renal Tubular Function and Hemodynamics: Flow States Location: Regency Ballroom C-F & Center Moderators: Brandi M Wynne, MS, PhD, FAHA and Patrick Osei-Owusu, PhD, FAHA 4:30 PM A Common ENaC Variant Promotes Salt-Sensitive Blood Pressure Evan C. Ray, MD, PhD 77 4:45 PM The Effects of a Novel Knockout of Histamine N-methyltransferase in Dahl SS Rats Corey Andrews 78 5:00 PM Principal Cell EP4 Receptor Suppresses ENaC to Prevent Sodium Retention During Angiotensin II Hypertension Caiping He 79 5:15 PM Activation of PIEZO Channels Restores Endothelial-Dependent Vasodilation in Renal Afferent Arterioles of Diabetic Mice Mariela Mendez 19B Pills, Pathways, and Precision: Emerging Hypertension Therapeutics Location: Presidents Quarters Moderators: Dr Heddwen Brooks PhD and Augusto Montezano PhD, FAHA 80 4:30 PM Baxdrostat Efficacy and Safety According to Demographic Characteristics: Subgroup Analyses of the BaxHTN Trial Jamie Dwyer 81 4:45 PM Initial Single-Pill vs Free-Pill Combination Therapy and Cardiovascular and Kidney Outcomes in Young Adults with Hypertension Kyoung Hwa Ha 82 5:00 PM CTX340TM, a CRISPR-CAS9 Gene Editor Targeting AGT, Achieves Robust and Durable Blood Pressure Control in Spontaneously Hypertensive Rats While Preserving Blood Pressure in Normotensive Non-Human Primates Kenneth Drombosky 83 5:15 PM Endothelin is a Driver of Hypertension in Individuals with Obesity: A Post-Hoc Analysis of the PRECISION Study Michael A Weber Concurrent C (Clinical Track Session) Multidisciplinary Approach to Hypertension Management with Lifestyle Strategies Moderators: Ian Kronish, MD, MPH, and Anika Hines, PhD, MPH, Med 4:30 PM Role of behavioral psychologist: Coaching techniques to help with implementation of traditional and nontraditional lifestyle modifications Kaushal Amatya, PhD 4:50 PM Role of the dietitian: Practical diet/salt strategies for hypertension management across the lifespan Kristie Lancaster, PhD 5:10 PM Weight loss strategies with and without GLP-1RAs Alexa Triot, MD
5:45 p.m. to 6:15 p.m.	Session 20 Excellence Award for Hypertension Research Lectures Location: Regency Ballroom C-F & Center 5:45PM Contributions to our Evolving Understanding of the Role of Angiotensin II in Hypertension Gregory Fink, PHD, FAHA 6:15 PM The Neuro-Immune-Cardiovascular Axis: A Journey Within Inter-Organ Crosstalk Through Clinical and Molecular Approaches Giuseppe Lembo, MD, PhD
7:30 p.m. to 10:00 p.m.	Hypertension Council Gala Dinner Location: McCormick and Schmick's (Ticket Required)

About This Meeting

Hypertension 2026 Scientific Sessions is considered the premier scientific meeting on the subject in the world. A collaborative effort between the Council on Hypertension and the Council on the Kidney in Cardiovascular Disease, the science submitted to this conference continues to bring us the most up to date developments on our understanding of: the causes of hypertension; its relationship to stroke, cardiac disease and kidney dysfunction; and the most effective means for detecting, evaluating and treating high blood pressure across diverse populations.

This year's programming also includes:

Recent Advances sessions
Lectures on cutting-edge science, followed by oral abstract presentations
Clinical Track featuring sessions focused on topics of direct relevance to clinicians, clinician-based scientists, and primary care physicians, emphasizing practical application, evidence-based practice, and translational insights.
Oral abstract sessions highlighting Early Career oral abstract presentations
Networking sessions
Trainee Advocacy Committee (TAC) Poster session and competition
Award Lecture sessions

2026 Learning Objectives

Discuss recent advances and emerging experimental models in hypertension and kidney disease.
Summarize findings from recent clinical trials and the impact on future treatment and/or management of hypertensive and kidney-related disorders.
Describe new therapeutic options and technologies for patients with hypertension and kidney disease.
Describe the most up-to-date clinical guideline recommendations for the prevention, diagnosis, and management of hypertension and kidney disease.
Describe innovative approaches to conducting basic and/or clinical research in hypertension and kidney disease.